A Phase 1 Single and Multiple Ascending Dose and Drug Drug Interaction Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics
Latest Information Update: 13 Jun 2025
At a glance
- Drugs Imapextide (Primary)
- Indications Hypoglycaemia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors MBX Biosciences
Most Recent Events
- 10 Jun 2025 According to a MBX Biosciences media release, data from this study will be presented at the American Diabetes Association's (ADA) 85th Scientific Sessions, taking place June 20-23. 2025, Chicago, IL.
- 07 Jan 2025 Results presented in the MBX Biosciences media release.
- 07 Jan 2025 According to a MBX Biosciences media release, the company announced positive results from this trial.